InvestorsObserver
×
News Home

What is the Market's View on Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock's Price and Volume Trends Tuesday?

Tuesday, February 27, 2024 12:48 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock's Price and Volume Trends Tuesday?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is lower by 2.04% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Bio-Rad Laboratories, Inc. Class A Common Stock has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on BIO!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With BIO Stock Today?

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) stock is trading at $336.75 as of 12:30 PM on Tuesday, Feb 27, a drop of -$1.41, or -0.42% from the previous closing price of $338.16. The stock has traded between $331.05 and $340.21 so far today. Volume today is light. So far 64,201 shares have traded compared to average volume of 230,340 shares. To screen for more stocks like Bio-Rad Laboratories, Inc. Class A Common Stock click here.

More About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier. Click Here to get the full Stock Report for Bio-Rad Laboratories, Inc. Class A Common Stock stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App